TY - JOUR
T1 - IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts
AU - Cunnusamy, Khrishen
AU - Chen, Peter W.
AU - Niederkorn, Jerry Y.
PY - 2011/6/15
Y1 - 2011/6/15
N2 - IL-17A is a proinflammatory cytokine that has received attention for its role in the pathogenesis of several autoimmune diseases. IL-17A has also been implicated in cardiac and renal allograft rejection. Accordingly, we hypothesized that depletion of IL-17A would enhance corneal allograft survival. Instead, our results demonstrate that blocking IL-17A in a mouse model of keratoplasty accelerated the tempo and increased the incidence of allograft rejection from 50 to 90%. We describe a novel mechanism by which CD4 +CD25+ regulatory T cells (Tregs) respond to IL-17A and enhance corneal allograft survival. Our findings suggest the following: 1) IL-17A is necessary for ocular immune privilege; 2) IL-17A is not required for the induction of anterior chamber-associated immune deviation; 3) Tregs require IL-17A to mediate a contact-dependent suppression; 4) corneal allograft Tregs suppress the efferent arm of the immune response and are Ag specific; 5) Tregs are not required for corneal allograft survival beyond day 30; and 6) corneal allograft-induced Treg-mediated suppression is transient. Our findings identify IL-17A as a cytokine essential for the maintenance of corneal immune privilege and establish a new paradigm whereby interplay between IL-17A and CD4 +CD25+ Tregs is necessary for survival of corneal allografts.
AB - IL-17A is a proinflammatory cytokine that has received attention for its role in the pathogenesis of several autoimmune diseases. IL-17A has also been implicated in cardiac and renal allograft rejection. Accordingly, we hypothesized that depletion of IL-17A would enhance corneal allograft survival. Instead, our results demonstrate that blocking IL-17A in a mouse model of keratoplasty accelerated the tempo and increased the incidence of allograft rejection from 50 to 90%. We describe a novel mechanism by which CD4 +CD25+ regulatory T cells (Tregs) respond to IL-17A and enhance corneal allograft survival. Our findings suggest the following: 1) IL-17A is necessary for ocular immune privilege; 2) IL-17A is not required for the induction of anterior chamber-associated immune deviation; 3) Tregs require IL-17A to mediate a contact-dependent suppression; 4) corneal allograft Tregs suppress the efferent arm of the immune response and are Ag specific; 5) Tregs are not required for corneal allograft survival beyond day 30; and 6) corneal allograft-induced Treg-mediated suppression is transient. Our findings identify IL-17A as a cytokine essential for the maintenance of corneal immune privilege and establish a new paradigm whereby interplay between IL-17A and CD4 +CD25+ Tregs is necessary for survival of corneal allografts.
UR - http://www.scopus.com/inward/record.url?scp=79959566615&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959566615&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1100101
DO - 10.4049/jimmunol.1100101
M3 - Article
C2 - 21551366
AN - SCOPUS:79959566615
SN - 0022-1767
VL - 186
SP - 6737
EP - 6745
JO - Journal of Immunology
JF - Journal of Immunology
IS - 12
ER -